Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 9 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026, Feb 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Oct 2026.
- Largest single sale: $518K (6,600 shares) of Ptc Therapeutics, Inc. on Jun 17, 2026. Filing
- Last sale before this period: Oct 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ptc Therapeutics, Inc. (PTCT) | Exec. VP and CLO | Jun 19, 2013 | Oct 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 9, 2026, Ptc Therapeutics, Inc.: sold 192 shares for $12K, under a disclosed plan; 192 shares acquired by exercising options. 1 filing: 1
- Oct 6, 2026, Ptc Therapeutics, Inc.: sold 435 shares for $28K, under a disclosed plan; 435 shares acquired by exercising options. 1 filing: 1
- Oct 5, 2026, Ptc Therapeutics, Inc.: sold 1,638 shares for $105K, under a disclosed plan; 1,638 shares acquired by exercising options. 1 filing: 1
- Aug 17, 2026, Ptc Therapeutics, Inc.: sold 2,813 shares for $204K, under a disclosed plan; 2,813 shares acquired by exercising options. 1 filing: 1
- Jul 6, 2026, Ptc Therapeutics, Inc.: sold 5,079 shares for $432K, under a disclosed plan; 2,266 shares vested or acquired by exercising options; 2,813 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.